OptimizeRx Corporation Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare

Reuters

2025/08/22

<a href="https://laohu8.com/S/OPRX">OptimizeRx Corporation</a> Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare

OptimizeRx Corporation has released a corporate presentation highlighting its role as a leading technology provider in the healthcare sector. The presentation details how OptimizeRx facilitates engagement between life sciences organizations, physicians, and patients, supporting patients in starting and adhering to therapy. The company operates a platform that connects a significant portion of U.S. physicians and patients, boasting approximately 130 employees in the United States and Croatia, with an average revenue per full-time employee exceeding $700K. As of mid-August 2025, OptimizeRx's stock price stood at $16.86, with a market capitalization of approximately $313.0 million. The company is listed on the NASDAQ Exchange under the ticker OPRX. You can access the full presentation through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief on August 21, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2561413821"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2561413821\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2561413821?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-22 02:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2561413821","market":"fut","top_or_hot":-1,"title":"OptimizeRx Corporation Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/OPRX\">OptimizeRx Corporation</a> Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        OptimizeRx Corporation has released a corporate presentation highlighting its role as a leading technology provider in the healthcare sector. The presentation details how OptimizeRx facilitates engagement between life sciences organizations, physicians, and patients, supporting patients in starting and adhering to therapy. The company operates a platform that connects a significant portion of U.S. physicians and patients, boasting approximately 130 employees in the United States and Croatia, with an average revenue per full-time employee exceeding $700K. As of mid-August 2025, OptimizeRx's stock price stood at $16.86, with a market capitalization of approximately $313.0 million. The company is listed on the NASDAQ Exchange under the ticker OPRX. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief on August 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>OptimizeRx Corporation Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOptimizeRx Corporation Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-08-22 02:57</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/OPRX\">OptimizeRx Corporation</a> Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        OptimizeRx Corporation has released a corporate presentation highlighting its role as a leading technology provider in the healthcare sector. The presentation details how OptimizeRx facilitates engagement between life sciences organizations, physicians, and patients, supporting patients in starting and adhering to therapy. The company operates a platform that connects a significant portion of U.S. physicians and patients, boasting approximately 130 employees in the United States and Croatia, with an average revenue per full-time employee exceeding $700K. As of mid-August 2025, OptimizeRx's stock price stood at $16.86, with a market capitalization of approximately $313.0 million. The company is listed on the NASDAQ Exchange under the ticker OPRX. You can access the full presentation through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief on August 21, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"醫療保健技術","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL9nRP4N:1","article_id":"2561413821","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2561413821","pubTimestamp":1755802621,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"OptimizeRx Corporation has released a corporate presentation highlighting its role as a leading technology provider in the healthcare sector. The presentation details how OptimizeRx facilitates engagement between life sciences organizations, physicians, and patients, supporting patients in starting and adhering to therapy. The company operates a platform that connects a significant portion of U.S. physicians and patients, boasting approximately 130 employees in the United States and Croatia, with an average revenue per full-time employee exceeding $700K. As of mid-August 2025, OptimizeRx's stock price stood at $16.86, with a market capitalization of approximately $313.0 million. The company is listed on the NASDAQ Exchange under the ticker OPRX. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generat","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","OPRX":"OptimizeRx Corporation"},"translate_title":"OptimizeRx Corporation推出新演示文稿，重点介绍医疗保健中患者参与的技术解决方案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OPRX":0.9},"content_text":"OptimizeRx Corporation Unveils New Presentation Highlighting Technology Solutions for Patient Engagement in Healthcare\n    \n\n        OptimizeRx Corporation has released a corporate presentation highlighting its role as a leading technology provider in the healthcare sector. The presentation details how OptimizeRx facilitates engagement between life sciences organizations, physicians, and patients, supporting patients in starting and adhering to therapy. The company operates a platform that connects a significant portion of U.S. physicians and patients, boasting approximately 130 employees in the United States and Croatia, with an average revenue per full-time employee exceeding $700K. As of mid-August 2025, OptimizeRx's stock price stood at $16.86, with a market capitalization of approximately $313.0 million. The company is listed on the NASDAQ Exchange under the ticker OPRX. You can access the full presentation through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OptimizeRx Corporation published the original content used to generate this news brief on August 21, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}